THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION
THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION
复制标题
DOI:
10.1016/0092-8674(90)90146-6
复制
发表时间:
1990-11-16
期刊:
影响因子:
64.5
通讯作者:
GREENE, WC
中科院分区:
文献类型:
--
作者:
BALLARD, DW;WALKER, WH;GREENE, WC
Studies of NF-.kappa.B suggest that this enhancer binding activity corresponds to a family of at least four proteins (p50, p55, p75, and p85) differentially induced with biphasic kinetics during T cell activation. While p55 and p50 are closely related to the 50 kd DNA binding subunit of NF-.kappa.B, p75 and p85 exhibit DNA binding properties that distinguish them from this 50 kd polypeptide and its regulatory subunits I.kappa.B and p65. All four members of this .kappa.B-specific protein family are structurally related to the v-Rel oncoprotein and one, p85, appears identical to human c-Rel. v-Rel, but not nontransforming v-Rel mutants, binds to the .kappa.B enhancer and inhibits the NF-.kappa.B-activated transcription from the IL-2 receptor .alpha. promoter and HIV-1 LTR. These findings suggest a Rel-related family of .kappa.B enhancer binding proteins and raise the possibility that the transforming activity of v-Rel is linked to its inhibitory action on cellular genes under NF-.kappa.B control.